Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy

The incidence and prevalence of diabetes mellitus (DM) are increasing worldwide, and the resulting cardiac complications are the leading cause of death. Among these complications is diabetes-induced cardiomyopathy (DCM), which is the consequence of a pro-inflammatory condition, oxidative stress and...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Jaqueline S., Gonçalves, Renata G. J., Vasques, Juliana F., Rocha, Bruna S., Nascimento-Carlos, Bianca, Montagnoli, Tadeu L., Mendez-Otero, Rosália, de Sá, Mauro P. L., Zapata-Sudo, Gisele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773977/
https://www.ncbi.nlm.nih.gov/pubmed/35053356
http://dx.doi.org/10.3390/cells11020240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773977/
https://www.ncbi.nlm.nih.gov/pubmed/35053356
http://dx.doi.org/10.3390/cells11020240

Ejemplares similares